Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-25 @ 11:48 PM
Study NCT ID:
NCT03986294
Status:
UNKNOWN
Last Update Posted:
2021-01-15
First Post:
2019-02-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Second Line Treatment With Nal-IRI and S1 in Pancreatic Cancer
Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2019-02-11
First Submit QC Date:
None
Study First Post Date:
2019-06-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-14
Last Update Post Date:
2021-01-15
Last Update Post Date Type:
ACTUAL